Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States

Emily Durden; Donna McMorrow; Paul Juneau; Robert Fowler; Paresh Chaudhari; David Horn

doi:10.36469/9862

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Infectious Diseases

Vol. 1, Issue 2, 2013

October 08, 2013 EDT

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States

Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn,

treatmentcostsburdeneconomicaspergillosis

ccby-4.0

• https://doi.org/10.36469/9862

JHEOR

Durden E, McMorrow D, Juneau P, Fowler R, Chaudhari P, Horn D. Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States. JHEOR. 2013;1(2):151-162. doi:10.36469/9862